Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 24;8(8):CD002311.
doi: 10.1002/14651858.CD002311.pub4.

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Wes Onland  1 , Martin Offringa, Anton van Kaam
Affiliations
Meta-Analysis

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Wes Onland et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks postmenstrual age (PMA), remains an important complication of prematurity. Pulmonary inflammation plays a central role in the pathogenesis of BPD. Attenuating pulmonary inflammation with postnatal systemic corticosteroids reduces the incidence of BPD in preterm infants but may be associated with an increased risk of adverse neurodevelopmental outcomes. Local administration of corticosteroids via inhalation might be an effective and safe alternative.

Objectives: To determine if administration of inhalation corticosteroids after the first week of life until 36 weeks PMA to preterm infants at high risk of developing BPD is effective and safe in reducing the incidence of death and BPD as separate or combined outcomes.

Search methods: We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 4), MEDLINE via PubMed (1966 to 19 May 2017), Embase (1980 to 19 May 2017), and CINAHL (1982 to 19 May 2017). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials.

Selection criteria: We included randomised controlled trials comparing inhalation corticosteroids, started ≥ 7 days postnatal age (PNA) but before 36 weeks PMA, to placebo in ventilated and non-ventilated infants at risk of BPD. We excluded trials investigating systemic corticosteroids versus inhalation corticosteroids.

Data collection and analysis: We collected data on participant characteristics, trial methodology, and inhalation regimens. The primary outcome was death or BPD at 36 weeks PMA. Secondary outcomes were the combined outcome death or BPD at 28 days PNA, the seperate outcomes of death and BPD at both 28 days PNA, and at 36 weeks PMA, and short-term respiratory outcomes, such as failure to extubate; total days of mechanical ventilation and oxygen use; and the need for systemic corticosteroids. We contacted the original trialists to verify the validity of extracted data and to provide missing data. We analysed all data using Review Manager 5. When possible, we performed meta-analysis using typical risk ratio (RR) for dichotomous outcomes and weighted mean difference (WMD) for continuous outcomes along with their 95% confidence intervals (CI). We analysed ventilated and non-ventilated participants separately.We used the GRADE approach to assess the quality of the evidence.

Main results: We included eight trials randomising 232 preterm infants in this review. Inhalation corticosteroids did not reduce the separate or combined outcomes of death or BPD. The meta-analyses of the studies showed a reduced risk in favor of inhalation steroids regarding failure to extubate at seven days (typical RR (TRR) 0.80, 95% CI 0.66 to 0.98; 5 studies, 79 infants) and at the latest reported time point after treatment onset (TRR 0.60, 95% CI 0.45 to 0.80; 6 studies, 90 infants). However, both analyses showed increased statistical heterogeneity (I2 statistic 73% and 86%, respectively). Furthermore, inhalation steroids did not impact total duration of mechanical ventilation or oxygen dependency. There was a trend toward a reduction in the use of systemic corticosteroids in infants receiving inhalation corticosteroids (TRR 0.51, 95% CI 0.26 to 1.00; 4 studies, 74 infants; very low-quality evidence). There was a paucity of data on short- and long-term adverse effects. Our results should be interpreted with caution because the total number of randomised participants is relatively small, and most trials differed considerably in participant characteristics, inhalation therapy, and outcome definitions.

Authors' conclusions: Based on the results of the currently available evidence, inhalation corticosteroids initiated at ≥ 7 days of life for preterm infants at high risk of developing BPD cannot be recommended at this point in time. More and larger randomised, placebo-controlled trials are needed to establish the efficacy and safety of inhalation corticosteroids.

PubMed Disclaimer

Conflict of interest statement

Wes Onland: No financial disclosure to be declared. No potential conflicts of interest known. Martin Offringa: No financial disclosure to be declared. No potential conflicts of interest known. Anton van Kaam: No financial disclosure to be declared. No potential conflicts of interest known.

Figures

1
1
Flow of inclusion of randomised controlled trials in different phases of search.
2
2
Study flow diagram: review update.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Arnon 1996 {published and unpublished data}
    1. Arnon S, Grigg J, Silverman M. Effectiveness of budesonide aerosol in ventilator‐dependent preterm babies: a preliminary report. Pediatric Pulmonology 1996;21(4):231‐5. [DOI: 10.1002/(SICI)1099-0496(199604)21:4%3C231::AID-PPUL5%3E3.0.CO;2-R; PUBMED: 9121852] - DOI - PubMed
Denjean 1998 {published data only (unpublished sought but not used)}
    1. Denjean A, Paris‐Llado J, Zupan V, Debillon T, Kieffer F, Magny JF, et al. Inhaled salbutamol and beclomethasone for preventing broncho‐pulmonary dysplasia: a randomised double‐blind study. European Journal of Pediatrics 1998;157(11):926‐31. [PUBMED: 9835439] - PubMed
Dugas 2005 {published and unpublished data}
    1. Dugas MA, Nguyen D, Frenette L, Lachance C, Belanger S, Caouette G, et al. Clinical outcome of inhaled fluticasone in moderate bronchopulmonary dysplasia. American Journal of Respiratory Critical Care Medicine 2003;167:A385.
    1. Dugas MA, Nguyen D, Frenette L, Lachance C, St‐Onge O, Fougeres A, et al. Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia. Pediatrics 2005;115(5):e566‐72. [DOI: 10.1542/peds.2004-0951; PUBMED: 15833887] - DOI - PubMed
    1. Piedboeuf B, Dugas MA, Nguyen D, Frenette L, Proulx E, Lachance C. Clinical outcome of inhaled fluticasone in moderate bronchopulmonary dysplasia. Pediatric Research 2003;53:411A. - PubMed
Giep 1996 {published data only (unpublished sought but not used)}
    1. Giep T, Raibble P, Zuerlein T, Schwartz ID. Trial of beclomethasone dipropionate by metered‐dose inhaler in ventilator‐dependent neonates less than 1500 grams. American Journal of Perinatology 1996;13(1):5‐9. [DOI: 10.1055/s-2007-994193; PUBMED: 8645387] - DOI - PubMed
    1. Schwartz ID, Giep T. Adrenal function in preterm infants treated with beclomethasone. Journal of Pediatrics 2000;136(6):851‐2. [PUBMED: 10839892] - PubMed
Jonsson 2000 {published and unpublished data}
    1. Jonsson B, Eriksson M, Soder O, Broberger U, Lagercrantz H. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease. Acta Paediatrica 2000;89(12):1449‐55. [PUBMED: 11195235] - PubMed
LaForce 1993 {published and unpublished data}
    1. LaForce WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen‐ and ventilator‐dependent infants. Journal of Pediatrics 1993;122(2):285‐8. [PUBMED: 8429447] - PubMed
Pappagallo 1998 {published data only (unpublished sought but not used)}
    1. Pappagallo M, Abbasi S, Bhutani VK. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependent preterm infants at risk for bronchopulmonary dysplasia. Indian Journal of Pediatrics 1998;65(2):273‐82. [PUBMED: 10771973] - PubMed
    1. Pappagallo M, Bhutani V, Abbasi S. Nebulised steroid trial in ventilator‐dependent preterm infants. Pediatric Research 1991;29:327A.
Pokriefka 1993 {published data only (unpublished sought but not used)}
    1. Pokriefka E, Mehdizadeh B, Rabbani A. Inhaled flunisolide in bronchopulmonary dysplasia. Pediatric Research 1993;33:341A.

References to studies excluded from this review

Abbasi 1993 {published data only}
    1. Abbasi S, Silva W, Gerdes JS, Bhutani VK. Role of dexamethasone therapy for severe trachebronchial mucosal lesions in mechanically ventilated preterm infants. Pediatric Research 1993; Vol. 33:198A.
Beresford 2002 {published data only}
    1. Beresford MW, Primhak R, Subhedar NV, Shaw NJ. Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. Archives of Disease in Childhood. Fetal and Neonatal Edition 2002;87(1):F62‐3. [PUBMED: 12091296] - PMC - PubMed
Cloutier 1993 {published data only}
    1. Cloutier M. Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatric Pulmonology 1993;15(2):111‐6. [PUBMED: 8474782] - PubMed
Cole 1999a {published data only}
    1. Cole CH, Abbasi S, Dorkin H, Shah B, Demissie S, Mackinnon B, et al. Early inhaled glucocorticoid therapy for prevention of BPD: assessment of growth, history, and pulmonary function at 6 months corrected age. Pediatric Research 1999;45:190A.
    1. Cole CH, Colton T, Shah BL, Abbasi S, MacKinnon BL, Demissie S, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. New England Journal of Medicine 1999;340(13):1005‐10. [DOI: 10.1056/NEJM199904013401304; PUBMED: 10099142] - DOI - PubMed
    1. Cole CH, Shah B, Abbasi S, Demissie S, Mackinnon B, Colton T, et al. Adrenal function in premature infants during inhaled beclomethasone therapy. Journal of Pediatrics 1999;135(1):65‐70. [PUBMED: 10393606] - PubMed
    1. Gupta GK, Cole CH, Abbasi S, Demissie S, Njinimbam C, Nielsen HC, et al. Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL‐8 and IL‐1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatric Pulmonology 2000;30(4):275‐81. [PUBMED: 11015126] - PubMed
    1. Gupta GK, Cole CH, Abbasi S, Nielsen HC, Demissie S, Colton T, et al. Effect of beclomethasone therapy on tracheal aspirate interleukine‐8 and interleukine‐1 receptor antagonist in preterm ventilated infants at risk for bronchopulmonary dysplasia (BPD). Pediatric Research 1998; Vol. 45:303A. - PubMed
Dimitriou 1997 {published data only}
    1. Dimitriou G, Greenough A, Giffin F, Kavadia V. Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. European Journal of Pediatrics 1997;156(1):51‐5. - PubMed
Dunn 1989 {published data only}
    1. Dunn MS, Magnani L, Belaiche M. Inhaled corticosteroids in severe bronchopulmonary dysplasia. Pediatric Research 1989;25:213A.
Dunn 1992 {published data only}
    1. Dunn M, Pandit P, Magnani L, Anaka R, Kirpalani H. Inhaled corticosteroids for neonatal chronic lung disease: a randomised, double‐blind cross‐over study. Pediatric Research 1992;31:201A.
Eisenberg 1990 {published data only}
    1. Eisenberg J. Use of nebulized flunisolide in infants and children with asthma and bronchopulmonary dysplasia. American Review of Respiratory Disease 1990;141:A899.
Giffin 1994 {published data only}
    1. Giffin F, Greenough A. A pilot study assessing inhaled budesonide in chronically oxygen‐dependent infants. Acta Paediatrica 1994;83(6):669‐71. [PUBMED: 7919769] - PubMed
Inwald 1999 {published data only}
    1. Inwald DP, Trivedi K, Murch SH, Costeloe K. The effect of early inhaled budesonide on pulmonary inflammation in infants with respiratory distress syndrome. European Journal of Pediatrics 1999;158(10):815‐6. [PUBMED: 10486083] - PubMed
Konig 1992 {published data only}
    1. Konig P, Shatley M, Levine C, Mawhinney T. Clinical observations of nebulised flunisolide in infants and young children with asthma and bronchopulmonary dysplasia. Pediatric Pulmonology 1992;13(4):209‐14. [DOI: 10.1002/ppul.1950130407] - DOI - PubMed
Kovacs 1998 {published data only}
    1. Kovacs L, Davis GM, Faucher D, Papageorgiou A. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatrica 1998;87(7):792‐8. [PUBMED: 9722255] - PubMed
    1. Kovacs L, Davis M, Faucher DJ, Papageorgiou AN. Efficacy of early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Pediatric Research 1996;39:337A. - PubMed
Kugelman 2017 {published data only}
    1. Kugelman A, Peniakov M, Zangen S, Shiff Y, Riskin A, Iofe A, et al. Inhaled hydrofluoalkane‐beclomethasone dipropionate in bronchopulmonary dysplasia. A double‐blind, randomized, controlled pilot study. Journal of Perinatology 2017;37(2):197‐202. [DOI: 10.1038/jp.2016.177; PUBMED: 27735931] - DOI - PubMed
Liu 1996 {published data only}
    1. Liu EA, Heldt GP. A trial of the safety of inhaled beclomethasone in ventilator‐treated neonates. Journal of Pediatrics 1996;129(1):154‐6. [PUBMED: 8757577] - PubMed
    1. Liu EA, Heldt GP. Effects of inhaled beclomethasone in intubated neonates: phase 1 trial. Pediatric Research 1993;33:334A.
Ng 1998 {published data only}
    1. Ng PC, Fok TF, Wong GW, Lam CW, Lee CH, Wong MY, et al. Pituitary‐adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. Journal of Clinical Endocrinology and Metabolism 1998;83(7):2390‐3. [DOI: 10.1210/jcem.83.7.4947; PUBMED: 9661616] - DOI - PubMed
Pappagallo 1990 {published data only}
    1. Pappagallo M, Blondheim O, Bhutani VK, Abbasi S. Effect of inhaled dexamethasone in ventilator dependent preterm infants. Pediatric Research 1990; Vol. 27:219A. - PubMed
Parikh 2002 {published data only}
    1. Parikh NA, Locke RG, Chidekel A, Leef KH, Emberger J, Paul DA, et al. Effect of inhaled corticosteroids on inflammatory cytokines in preterm infants with evolving chronic lung disease. Pediatric Research 2002;51:356A. - PubMed
    1. Parikh NA, Locke RG, Chidekel A, Leef KH, Emberger J, Paul DA, et al. Effect of inhaled corticosteroids on markers of pulmonary inflammation and lung maturation in preterm infants with evolving chronic lung disease. Journal of the American Osteopathic Association 2004;104(3):114‐20. [PUBMED: 15083986] - PubMed
Pelkonen 2001 {published data only}
    1. Pelkonen AS, Hakulinen AL, Hallman M, Turpeinen M. Effect of inhaled budesonide therapy on lung function in schoolchildren born preterm. Respiratory Medicine 2001;95(7):565‐70. [DOI: 10.1053/rmed.2001.1104; PUBMED: 11453312] - DOI - PubMed
Rajamani 1998 {published data only}
    1. Rajamani S, Dothey C, Super D, Martin J. Early inhaled beclomethasone does not alter the course of lung disease in very low birth weight infants (VLBW) at risk of bronchopulmonary dysplasia (BPD). Pediatric Research 1998;45:219A.
Rozycki 2003 {published data only}
    1. Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology 2003;35(5):375‐83. - PubMed
Shah 2007 {published data only}
    1. Jangaard K, Vincer MJ, Dunn M, Asztalos E, Shah VS. Neurodevelopmental outcomes in ventilated preterm infants < 1250 grams enrolled in a dose‐ranging study assessing the effect of inhaled corticosteroids. Pediatric Academic Societies (PAS) 2009 Annual Meeting; 2009 May 02 ‐ 05; Baltimore (MD). Baltimore (MD), 2009. [4347.301]
    1. Shah VS, Jangaard K, Reilly M, Dunn M. Inhaled corticosteroids in ventilated preterm infants: an escalating dose‐ranging study. Pediatric Academic Societies (PAS) 2007 Annual Meeting; 2007 May 03 ‐ 08; Toronto (ON). Toronto (ON), 2007:E‐PAS2007:7935.21. [E‐PAS2007:7935.21]
Suchomski 1996 {published data only}
    1. Suchomski S, Cummings J. Randomised trial of inhaled vs intravenous steroid in ventilator dependent preterm infants. Pediatric Research 1996;39:247A. - PubMed
    1. Suchomski SJ, Cummings JJ. A randomized trial of inhaled versus intravenous steroids in ventilator‐dependent preterm infants. Journal of Perinatology 2002;22(3):196‐203. [DOI: 10.1038/sj.jp.7210705; PUBMED: 11948381] - DOI - PubMed
Thorson 1992 {published data only}
    1. Gal P, Diaz PR, Ransom JL, Carlos RQ, Thorson DW. Beclomethasone for treating premature infants with bronchopulmonary dysplasia. Journal of Pediatrics 1993;123(3):490‐1. [PUBMED: 8355132] - PubMed
    1. Thorson DW, Gal P, Diaz PR, Ransom JL, Weaver RL, Carlos RQ. Beclomethasone MDI for treating bronchopulmonary dysplasia in premature infants: a preliminary report. Pharmacotherapy 1992;12:261.
Yeh 2008 {published data only}
    1. Yeh TF, Lin HC, Chang CH, Wu TS, Su BH, Li TC, et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008;121(5):e1310‐8. [DOI: 10.1542/peds.2007-1973; PUBMED: 18426851] - DOI - PubMed
Yuksel 1992 {published data only}
    1. Yuksel B, Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 1992;47(11):910‐3. [PUBMED: 1465747] - PMC - PubMed

Additional references

Bolton 2015
    1. Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L. Lung consequences in adults born prematurely. Thorax 2015;70(6):574‐80. [DOI: 10.1136/thoraxjnl-2014-206590; PUBMED: 25825005] - DOI - PubMed
Cheong 2013
    1. Cheong JL, Anderson P, Roberts G, Duff J, Doyle LW, Victorian Infant Collaborative Study Group. Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15‐year experience in Victoria, Australia. Archives of Disease in Childhood. Fetal and Neonatal Edition 2013;98(1):F32‐6. [DOI: 10.1136/fetalneonatal-2011-301355; PUBMED: 22684163] - DOI - PubMed
Davis 2001
    1. Davis PG, Henderson‐Smart DJ. Intravenous dexamethasone for extubation of newborn infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000308] - DOI - PubMed
Doyle 2006
    1. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006;118(1):108‐13. [DOI: 10.1542/peds.2005-2522; PUBMED: 16818555] - DOI - PubMed
Doyle 2014
    1. Doyle LW, Ehrenkranz RA, Halliday HL. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD001145.pub3; PUBMED: 24825542] - DOI - PubMed
Doyle 2014a
    1. Doyle LW, Ehrenkranz RA, Halliday HL. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD001146.pub4; PUBMED: 24825456] - DOI - PubMed
Fok 1996
    1. Fok TF, Monkman S, Dolovich M, Gray S, Coates G, Paes B, et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatric Pulmonology 1996;21(5):301‐9. [DOI: 10.1002/(SICI)1099-0496(199605)21:5%3C301::AID-PPUL5%3E3.0.CO;2-P; PUBMED: 8726155] - DOI - PubMed
GRADEpro GDT [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Version (accessed 19 May 2017). Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Higgins 2011
    1. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Ibrahim 2011
    1. Ibrahim H, Sinha IP, Subhedar NV. Corticosteroids for treating hypotension in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003662] - DOI - PMC - PubMed
Job 2015
    1. Job S, Clarke P. Current UK practices in steroid treatment of chronic lung disease. Archives of Disease in Childhood. Fetal and Neonatal Edition 2015; Vol. 100, issue 4:F371. [DOI: 10.1136/archdischild-2014-308060; PUBMED: 25762149] - DOI - PubMed
Jobe 2001
    1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 2001;163(7):1723‐9. [DOI: ; PUBMED: 10.1164/ajrccm.163.7.2011060] - PubMed
Maas 2010
    1. Maas C, Poets CF, Bassler D. Survey of practices regarding utilization of inhaled steroids in 223 German neonatal units. Neonatology 2010;98(4):404‐8. [DOI: 10.1159/000316978; PUBMED: 21051910] - DOI - PubMed
McEvoy 2014
    1. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL. Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Annals of the American Thoracic Society 2014;11(Suppl 3):S146‐53. [DOI: 10.1513/AnnalsATS.201312-424LD; PUBMED: 24754823] - DOI - PMC - PubMed
Ogawa 2015
    1. Ogawa R, Mori R, Sako M, Kageyama M, Tamura M, Namba F. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey. Pediatrics International 2015;57(1):189‐92. [DOI: 10.1111/ped.12584; PUBMED: 25711265] - DOI - PubMed
Onland 2017
    1. Onland W, Jaegere AP, Offringa M, Kaam A. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD010941.pub2; PUBMED: 28141913] - DOI - PMC - PubMed
Pierce 1995
    1. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatric Pulmonology 1995;19(6):371‐8. [PUBMED: 7567218] - PubMed
RevMan 5 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A (editors), GRADE Working Group. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. gdt.gradepro.org/app/handbook/handbook.html (accessed prior to 1 August 2017).
Shah 2012
    1. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002058.pub2; PUBMED: 22592683] - DOI - PubMed
Shah 2012a
    1. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002057.pub3; PUBMED: 22592682] - DOI - PubMed
Shah 2017
    1. Shah VS, Ohlsson A, Halliday HL, Dunn M. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4; PUBMED: 28052185] - DOI - PMC - PubMed
Short 2007
    1. Short EJ, Kirchner HL, Asaad GR, Fulton SE, Lewis BA, Klein N, et al. Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity‐based classification system. Archives of Pediatrics and Adolescent Medicine 2007;161(11):1082‐7. [DOI: 10.1001/archpedi.161.11.1082; PUBMED: 17984411] - DOI - PMC - PubMed
Slaughter 2014
    1. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. PLoS ONE 2014;9(9):e106838. [DOI: 10.1371/journal.pone.0106838; PUBMED: 25192252] - DOI - PMC - PubMed
Stoll 2010
    1. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126(3):443‐56. [DOI: 10.1542/peds.2009-2959; PUBMED: 20732945] - DOI - PMC - PubMed
Walsh 2005
    1. Walsh MC, Morris BH, Wrage LA, Vohr BR, Poole WK, Tyson JE, et al. National Institute of Child Health and Human Development Neonatal Research Network. Extremely low birthweight neonates with protracted ventilation: mortality and 18‐month neurodevelopmental outcomes. Journal of Pediatrics 2005;146(6):798‐804. [DOI: 10.1016/j.jpeds.2005.01.047; PUBMED: 15973322] - DOI - PubMed
Walsh 2006
    1. Walsh MC, Yao Q, Horbar JD, Carpenter JH, Lee SK, Ohlsson A. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 2006;118(5):e1328‐35. [DOI: 10.1542/peds.2006-0359; PUBMED: 17079534] - DOI - PubMed
Ward 2003
    1. Ward MC, Sinn JKH. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003485; PUBMED: 14583981] - DOI - PMC - PubMed
Yoder 2009
    1. Yoder BA, Harrison M, Clark RH. Time‐related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Pediatrics 2009;124(2):673‐9. [DOI: 10.1542/peds.2008-2793; PUBMED: 19620192] - DOI - PubMed

References to other published versions of this review

Lister 2000
    1. Lister P, Iles R, Shaw BNJ, Ducharme FM. Inhaled steroids for neonatal chronic lung disease. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002311] - DOI - PubMed
Onland 2012
    1. Onland W, Offringa M, Kaam A. Late (>/= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002311.pub3; PUBMED: 22513906] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources